Samuel Goldhaber, MD
Enriched profileAssociate Chief and Clinical Director, Division of Cardiovascular Medicine; Section Head, Vascular Medicine; Director, Thrombosis Research Group, Brigham and Women's Hospital · Brigham and Women's Hospital
Samuel Goldhaber is Associate Chief and Clinical Director, Division of Cardiovascular Medicine; Section Head, Vascular Medicine; Director, Thrombosis Research Group, Brigham and Women's Hospital at Brigham and Women's Hospital. OpenAlex indexes 1,086 publications with 93,635 citations (h-index 136); ClinicalTrials.gov lists 16 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Samuel Goldhaber is Associate Chief and Clinical Director, Division of Cardiovascular Medicine at Brigham and Women's Hospital. The public record shows 1,086 publications with 93,635 citations (h-index 136), centered on Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, Acute Myocardial Infarction Research. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 1 companies, 2 NIH-funded awards (1987–1999).
- Most recent indexed publication: 2026 · Circulation. Cardiovascular imaging
- Top research focus: Venous Thromboembolism Diagnosis and Management
- 16 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 578.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)
Sponsor: Brigham and Women's Hospital
- Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
Sponsor: Brigham and Women's Hospital
Industry payments
Updated 27 Aug 2026
1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:
- Agile Therapeutics, Inc.Program year20215 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
66.1%Statin22.9%Rosuvastatin Calcium47%Atorvastatin Calcium44%Simvastatin4%Pravastatin Sodium3%Pitavastatin Calcium2%Part D<11 patientsBeta blocker12%Metoprolol Succinate85%Atenolol6%Carvedilol5%Acebutolol Hcl5%Part D<11 patientsBlood & clotting
24.7%Factor Xa inhibitor21.3%Eliquis52%Xarelto36%Fondaparinux Sodium6%Savaysa5%Part D<11 patientsP2Y12 inhibitor2.4%Clopidogrel100%Part D≥18 patientsMetabolism & gastrointestinal
8.1%SGLT2 inhibitor5.3%Jardiance100%Part D≥35 patientsGLP-1 receptor agonist2.1%Ozempic78%Trulicity22%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 1987–1999 per NIH RePORTER. The latest:
- OUTPATIENT VS HOSPITAL TREATMENT OF DEEP VEIN THROMBOSIS
Brigham and Women'S Hospital
FY1999M01RR002635 - OUTPATIENT VS HOSPITAL TREATMENT OF DEEP VEIN THROMBOSIS
Brigham and Women'S Hospital
FY1998M01RR002635 - OUTPATIENT TREATMENT OF DEEP VENOUS THROMBOSIS--INPATIENT STUDY
Brigham and Women'S Hospital
FY1997M01RR002635
Congress activity
Updated 27 Aug 2026
4 congress contributions (2006–2021) across ASH, ASTRO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Increased Venous Volumes in Response to Catheter-Based Intervention for Acute PE: Lessons From the OPTALYSE PE Trial (OPTALYSE-3D).
Circulation. Cardiovascular imaging
Letter2026 - Adjudicated Cardiovascular Events in Patients With COVID-19: Association With Vaccination Status and Changes over Time.
Journal of the American Heart Association
Article2025 - Community Socioeconomic Status, Acute Cardiovascular Hospitalizations, and Mortality in Medicare, 2003 to 2019.
Circulation. Cardiovascular quality and outcomes
Article2024 - Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE).
Circulation. Cardiovascular interventions
Article2024 - Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study.
Journal of thrombosis and thrombolysis
Article2022
Most-cited works
by citation count (OpenAlex)- 01Antithrombotic Therapy for VTE DiseaseArticle6,153 citations2012
- 02
- 03
- 04
- 05Dabigatran versus Warfarin in the Treatment of Acute Venous ThromboembolismArticle2,579 citations2009
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/samuel-goldhaber-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/samuel-z-goldhaber-md-b984497
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Samuel-Goldhaber
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
thrombosis.org/about/samuel-z-goldhaber
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thrombosis.org ↗ - YouTube
m.youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →m.youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- Board Certified
Cardiovascular Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thrombosis.org ↗
- President
Emeritus, Vasculearn Network (VLN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thrombosis.org ↗ - Chair
Steering Committee, NHLBI-sponsored ATTRACT Trial (DVT treatment)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.harvard.edu ↗
- Certificate of Appreciation
Office of the Surgeon General of the United States, for contributions to venous thromboembolism prevention
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thrombosis.org ↗
Secondary affiliations
appointments beyond the home institution- Professor of Medicine
Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Media & interviews
press, podcasts and appearances- Host
"Clot Blog with Dr. Sam Goldhaber" - ongoing Medscape video/commentary series on thrombosis and anticoagulation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital